Monte Rosa (GLUE) | Stock Overview & Key Data

Monte Rosa Therapeutics Inc. | Healthcare

$4.64

3.11%

| Monte Rosa Stock Comparison:

Monte Rosa vs Vertex Monte Rosa vs Regeneron Monte Rosa vs Astria Therapeutics Monte Rosa vs Tevogen Bio Holdings Monte Rosa vs Ocugen Monte Rosa vs S&P 500 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Monte Rosa Performance Comparison

Loading chart data...

Monte Rosa

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $4.35 High: $4.82

on June 3, 2025

52 Week Range

Low: $3.21 High: $12.40

on June 28, 2024

on October 28, 2024

All-Time High: $45.56 on September 6, 2021

Key Statistics

Market Cap i $249.7M

EPS i 0.12

P/E Ratio (TTM) i 33.83

Forward P/E i -2.71

P/B Ratio i 0.91

PEG Ratio i -2.71

Div. Yield i 0.00%

ROE i 2.88%

Beta i 1.522

Debt to Equity i 15.21

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i 51.85%

Profit Margin i 3.86%

Returns and Earnings

Return on Assets (TTM) i -0.40%

Return on Equity (TTM) i 2.88%

EBITDA i $6.1M

Net Income (TTM) i $6.2M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Monte Rosa GLUE	249.73M Micro-cap	16.29%	0.22%	-16.40%	-52.94%	-34.74%	16.58%	-36.87%	-75.40%
Vertex VRTX	114.81B Large-cap	0.11%	-10.74%	-7.62%	-2.30%	10.04%	-7.56%	75.18%	66.26%
Regeneron REGN	65.36B Large-cap	-19.13%	-19.17%	-28.77%	-34.91%	-31.79%	-51.37%	-14.70%	-17.11%
Astria Therapeutics ATXS	246.62M Micro-cap	21.27%	-2.94%	-18.69%	-51.52%	-44.70%	-43.95%	76.51%	-87.38%
Tevogen Bio Holdings TVGN	246.42M Micro-cap	-0.78%	20.75%	8.47%	8.47%	20.75%	54.22%	-72.47%	-72.47%
Ocugen OCGN	243.61M Micro-cap	-11.46%	11.84%	39.34%	-5.56%	-5.56%	-46.88%	-60.83%	214.81%

Ownership & Short Interest

Insider Ownership i 0.72%

Institutional Ownership i 100.89%

Shares Short i 8M

Short Ratio i 9.49

Short % of Shares Outstanding i 16.98%

Average 10-Day Volume i 436K

Average 90-Day Volume i 473K

Monte Rosa Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Monte Rosa would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is GLUE's 52-week high and low?

In the last 52 weeks, Monte Rosa reached a high of $12.40 (on October 28, 2024) and a low of $3.21 (on June 28, 2024).

What is the market cap and P/E ratio for GLUE?

Curious about Monte Rosa's size and valuation? Its market capitalization stands at 249.73M. When it comes to valuation, the P/E ratio (trailing twelve months) is 33.83, and the forward P/E (looking ahead) is -2.71.

Does GLUE pay dividends? If so, what's the yield?

As for dividends, Monte Rosa isn't currently offering a significant yield, or that specific data isn't available right now. Its payout ratio, which shows how much of its earnings are paid as dividends, is 0.00%.

Who are Monte Rosa's main competitors or similar companies to consider before investing?

When looking at Monte Rosa, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Vertex VRTX	114.81B	Healthcare	Biotechnology	-7.56%	75.18%
Regeneron REGN	65.36B	Healthcare	Biotechnology	-51.37%	-14.70%
Astria Therapeutics ATXS	246.62M	Healthcare	Biotechnology	-43.95%	76.51%
Tevogen Bio Holdings TVGN	246.42M	Healthcare	Biotechnology	54.22%	-72.47%
Ocugen OCGN	243.61M	Healthcare	Biotechnology	-46.88%	-60.83%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Monte Rosa Therapeutics Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Monte Rosa's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 2.88%, the Debt to Equity ratio from the most recent quarter is 15.21, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for GLUE?

Looking at Monte Rosa's growth, its revenue over the trailing twelve months (TTM) was $159M. Compared to the same quarter last year (YoY), quarterly revenue grew by 7,882.00%, and quarterly earnings saw a YoY growth of 7,882.05%.

How much of GLUE stock is held by insiders and institutions?

Wondering who owns Monte Rosa stock? Company insiders (like executives and directors) hold about 0.72% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 100.89%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.